ReviewFrontiers in immunology2014

Peptide inhibitor of complement c1, a novel suppressor of classical pathway activation: mechanistic studies and clinical potential.

Julia A Sharp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.